SG Americas Securities, LLC - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 20 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$2,877,000
+27.6%
34,820
+54.1%
0.02%
+45.5%
Q3 2021$2,255,000
-58.6%
22,600
-58.7%
0.01%
-56.0%
Q2 2021$5,443,000
+10.6%
54,700
+15.4%
0.02%
-3.8%
Q1 2021$4,922,000
+53.3%
47,420
+36.9%
0.03%
+52.9%
Q4 2020$3,210,000
-30.9%
34,630
-39.2%
0.02%
-43.3%
Q3 2020$4,644,00056,9600.03%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 157,390,000$141,877,0003.17%
Birch Grove Capital LP 8,000,000$7,200,0002.94%
PFM Health Sciences, LP 48,150,000$43,919,0001.64%
SILVERBACK ASSET MANAGEMENT LLC 8,505,000$7,665,0001.04%
DAFNA Capital Management LLC 1,500,000$1,345,0000.35%
DeepCurrents Investment Group LLC 8,696,000$7,756,0000.24%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 11,092,000$10,005,0000.23%
ADVENT CAPITAL MANAGEMENT /DE/ 9,235,000$8,358,0000.13%
Verition Fund Management LLC 2,441,000$2,227,0000.03%
CAPSTONE INVESTMENT ADVISORS, LLC 6,000,000$5,473,0000.02%
View complete list of AERIE PHARMACEUTICALS INC shareholders